History, Dynamics, and Public Health Importance of Malaria Parasite Resistance-Reference-Cited by-同舟云学术

History, Dynamics, and Public Health Importance of Malaria Parasite Resistance

Published:2004-01 Issue:1 Volume:17 Page:235-254
ISSN:0893-8512
Container-title:Clinical Microbiology Reviews
language:en
Short-container-title:Clin Microbiol Rev

Author:

Talisuna Ambrose O.¹²³,Bloland Peter¹²³,D’Alessandro Umberto¹²³

Affiliation:

1. Ministry of Health, Epidemiological Surveillance Division, Kampala, Uganda

2. Prince Leopold Institute of Tropical Medicine and Hygiene, Antwerp, Belgium

3. Malaria Epidemiology Branch, Division of Parasitic Disease, National Center for Infectious Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia

Abstract

SUMMARY Despite considerable efforts, malaria is still one of the most devastating infectious diseases in the tropics. The rapid spread of antimalarial drug resistance currently compounds this grim picture. In this paper, we review the history of antimalarial drug resistance and the methods for monitoring it and assess the current magnitude and burden of parasite resistance to two commonly used drugs: chloroquine and sulfadoxine-pyrimethamine. Furthermore, we review the factors involved in the emergence and spread of drug resistance and highlight its public health importance. Finally, we discuss ways of dealing with such a problem by using combination therapy and suggest some of the research themes needing urgent answers.

Publisher

American Society for Microbiology

Subject

Infectious Diseases,Microbiology (medical),Public Health, Environmental and Occupational Health,General Immunology and Microbiology,Epidemiology

Link

https://journals.asm.org/doi/pdf/10.1128/CMR.17.1.235-254.2004

Reference238 articles.

1. Ache, A., M. Escorihuela, E. Vivas, E. Paez, L. Miranda, A. Matos, W. Perez, O. Diaz, and E. Izarra. 2002. In vivo drug resistance of falciparum malaria in mining areas of Venezuela. Trop. Med. Int. Health7:737-743.

2. al Arishi, H. M., A. F. el Awad, and L. A. al Bishi. 2001. Chloroquine-resistant Plasmodium falciparum malaria among children seen in a regional hospital, Tabuk, Saudi Arabia. Trans. R. Soc. Trop. Med. Hyg.95:439-440.

3. Alecrim, M. D., W. Alecrim, and V. Macedo. 1999. Plasmodium vivax resistance to chloroquine (R2) and mefloquine (R3) in Brazilian Amazon region. Rev. Soc. Bras. Med. Trop.32:67-68.

4. Alene, G. D., and S. Bennett. 1996. Chloroquine resistance of Plasmodium falciparum malaria in Ethiopia and Eritrea. Trop. Med. Int. Health1:810-815.

5. Anabwani, G. M., F. O. Esamai, and D. A. Menya. 1996. A randomised controlled trial to assess the relative efficacy of chloroquine, amodiaquine, halofantrine and Fansidar in the treatment of uncomplicated malaria in children. East Afr. Med. J.73:155-158.

Cited by 228 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Where do we stand? Insight on patented products and those under clinical trials;Advances in Antiparasitic Therapies and Drug Delivery;2024

2. Plasmodium;Molecular Medical Microbiology;2024

3. The problem of antimalarial resistance and its implications for drug discovery;Expert Opinion on Drug Discovery;2023-12-18

4. Plasmodium falciparum Genetic Diversity and Resistance Genotype Profile in Infected Placental Samples Collected After Delivery in Ouagadougou;Infection and Drug Resistance;2023-10

5. Nanoparticles for Antiparasitic Drug Delivery;Parasitic Infections;2023-07-20